Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C17H29NO5.Na.H |
Molecular Weight | 351.4136 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H+].[Na+].CCCCCCCCCCCC(=O)N[C@@H](CCC([O-])=O)C([O-])=O
InChI
InChIKey=IWIUXJGIDSGWDN-UQKRIMTDSA-M
InChI=1S/C17H31NO5.Na/c1-2-3-4-5-6-7-8-9-10-11-15(19)18-14(17(22)23)12-13-16(20)21;/h14H,2-13H2,1H3,(H,18,19)(H,20,21)(H,22,23);/q;+1/p-1/t14-;/m0./s1
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | BRIGHTENING DYNAMICS TRAVELING KIT JAFRA Approved UseHelps prevent sunburn. If used as directed, with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. Launch Date2014 |
PubMed
Title | Date | PubMed |
---|---|---|
Architecture of a biocompatible supramolecular material by supersaturation-driven fabrication of its fiber network. | 2005 Dec 29 |
|
Real-time observation of fiber network formation in molecular organogel: supersaturation-dependent microstructure and its related rheological property. | 2006 Apr 13 |
|
Drug solubilization effect of lauroyl-L-glutamate. | 2012 Jan |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C085318
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY | |||
|
DTXSID90885464
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY | |||
|
23668603
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY | |||
|
249-958-3
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY | |||
|
NCX1UU2D33
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY | |||
|
NCX1UU2D33
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY | |||
|
1364850
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY | RxNorm | ||
|
29923-31-7
Created by
admin on Fri Dec 15 18:05:32 GMT 2023 , Edited by admin on Fri Dec 15 18:05:32 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD